Eletriptan
| Klinički podaci | |
|---|---|
| Prodajno ime | Relpax |
| Drugs.com | Monografija |
| MedlinePlus | a603029 |
| Kategorija trudnoće |
|
| Način primene | oralnot |
| Pravni status | |
| Pravni status |
|
| Identifikatori | |
| CAS broj | 143322-58-1 |
| ATC kod | N02CC06 (WHO) |
| PubChem | CID 77993 |
| IUPHAR/BPS | 40 |
| DrugBank | DB00216 |
| ChemSpider | 70379 |
| UNII | 22QOO9B8KI |
| KEGG | D01973 |
| ChEBI | CHEBI:50922 |
| ChEMBL | CHEMBL1510 |
Eletriptan (Relpaks, Relert) je član druge generacije triptanski lekova namenjenih tretmanu migrenske glavobolje. On se korist kao blokiranje migrenskih napada koji su već u toku.
FDA je odobrila eletriptan 2002 za akutni tretman migrene kod odraslih.[1] On je dostupan samo na recept u SAD-u k Kanadi. On nije namenjen za profilaktičku terapiju migrene ili za upotrebu u kontroli hemiplegične ili bazilarne migrene. Eletriptan je pokriven U.S. Patent no. 5545644[1][2] and U.S. Patent no. 6110940;[1][3] the FDA lists the patents as scheduled for expiration on December 26, 2016, and August 29, 2017, respectively.}-[1]
Reference
- ^ а б в г FDA AccessData entry for Eletriptan Hydrobromide Архивирано на веб-сајту Wayback Machine (3. март 2016), accessed March 10, 2010.
- ^ U.S. Patent no. 5545644, -{John E. Macor & Martin J. Wythes, Indole Derivatives, August 13, 1996.
- ^ U.S. Patent no. 6110940, Valerie Denise Harding, et al., Salts of an anti-migraine indole derivative, August 29, 2000.
Spoljašnje veze
| Molimo Vas, obratite pažnju na važno upozorenje u vezi sa temama iz oblasti medicine (zdravlja). |
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.